A Milestone for CAR T Cells

More than 7 years have passed since the regression of advanced lymphoma was first reported in a patient who had undergone the infusion of T cells engineered to express a chimeric antigen receptor (CAR) targeting the CD19 antigen expressed on the surface of both normal and malignant B cells.…

from Cancer via ola Kala on Inoreader http://ift.tt/2yWsX8S
via IFTTT